Active Ingredient: LISINOPRIL
Proprietary Name: LISINOPRIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208920
Product Number: 001
Approval Date: Mar 4, 2021
Applicant Holder Full Name: SCIEGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information